Antiviral Therapy in Decompensated Hepatitis C Virus (HCV) Cirrhosis

Summary

To evaluate: 1. the impact of combined antiviral therapy (Peginterferon plus ribavirin) on natural history of patients affected with HCV decompensated cirrhosis, after sustained virological response. A controlled study. 2. safety and efficacy of antiviral therapy in this population by using a statistically significally number of patients as controls.

Timeline

Start

2002-01

Primary completion

—

Completion

2005-12

Drugs

Indications